Drug recall
Apheresis Red Blood Cells, Leukocytes Reduced
FDA recall event 84258 · Class II · BloodCenter of Wisconsin, Inc
Key facts
| Event ID | 84258 |
|---|---|
| Recall numbers | B-0134-2020, B-0135-2020, B-0136-2020, B-0137-2020 |
| Recalling firm | BloodCenter of Wisconsin, Inc |
| Product type | Biologics |
| Products | Apheresis Red Blood Cells, Leukocytes Reduced, Blood and Blood Products for Reprocessing, PF24 Plasma, Red Blood Cells, Leukocytes Reduced |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Blood products where transfusion-transmitted infection testing was incorrectly interpreted, were distributed. |
| Initiation date | Sep 19, 2019 |
| Report date | Dec 4, 2019 |
| Termination date | Nov 26, 2019 |
| City | Milwaukee |
| State | WI |
| Country | United States |
| FEI number | 2171378 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: